| PCDHGA6 | protocadherin gamma subfamily A, 6 | 5q31
| 4.615 |
| PCDHGB3 | protocadherin gamma subfamily B, 3 | 5q31
| 4.49 |
| PCDHGA7 | protocadherin gamma subfamily A, 7 | 5q31
| 4.478 |
| PCDHGB4 | protocadherin gamma subfamily B, 4 | 5q31
| 4.411 |
| PCDHGB5 | protocadherin gamma subfamily B, 5 | 5q31
| 4.411 |
| APC2 | adenomatosis polyposis coli 2 | 19p13.3
| 4.406 |
| PCDHGA8 | protocadherin gamma subfamily A, 8 | 5q31
| 4.374 |
| PCDHGA9 | protocadherin gamma subfamily A, 9 | 5q31
| 4.324 |
| LOC100288152 | NA | NA
| 4.289 |
| PP7080 | NA | NA
| 4.28 |
| PCDHA6 | protocadherin alpha 6 | 5q31
| 4.276 |
| PCDHA5 | protocadherin alpha 5 | 5q31
| 4.259 |
| PCDHGB6 | protocadherin gamma subfamily B, 6 | 5q31
| 4.214 |
| PCDHA7 | protocadherin alpha 7 | 5q31
| 4.196 |
| PCDHGA12 | protocadherin gamma subfamily A, 12 | 5q31
| 4.186 |
| PCDHA3 | protocadherin alpha 3 | 5q31
| 4.181 |
| PCDHGA5 | protocadherin gamma subfamily A, 5 | 5q31
| 4.174 |
| PCDHGB8P | protocadherin gamma subfamily B, 8 pseudogene | 5q31.3
| 4.161 |
| PCDHA4 | protocadherin alpha 4 | 5q31
| 4.158 |
| PCDHGA11 | protocadherin gamma subfamily A, 11 | 5q31
| 4.137 |
| PCDHGA10 | protocadherin gamma subfamily A, 10 | 5q31
| 4.134 |
| PCDHA9 | protocadherin alpha 9 | 5q31
| 4.129 |
| PCDHGB7 | protocadherin gamma subfamily B, 7 | 5q31
| 4.128 |
| C19orf25 | chromosome 19 open reading frame 25 | 19p13.3
| 4.103 |
| PCDHA8 | protocadherin alpha 8 | 5q31
| 4.052 |
| PCDHA10 | protocadherin alpha 10 | 5q31
| 4.046 |
| PCDHA2 | protocadherin alpha 2 | 5q31
| 3.988 |
| HMHA1 | histocompatibility (minor) HA-1 | 19p13.3
| 3.965 |
| C17orf82 | chromosome 17 open reading frame 82 | 17q23.2
| 3.929 |
| TBX2 | T-box 2 | 17q23.2
| 3.919 |
| TBX2-AS1 | TBX2 antisense RNA 1 | 17q23.2
| 3.903 |
| PCDHGB2 | protocadherin gamma subfamily B, 2 | 5q31
| 3.837 |
| SLC9A3 | solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | 5p15.3
| 3.717 |
| PCDHA11 | protocadherin alpha 11 | 5q31
| 3.649 |
| HCN2 | hyperpolarization activated cyclic nucleotide gated potassium channel 2 | 19p13
| 3.633 |
| MIR4456 | microRNA 4456 | 5
| 3.607 |
| TAS1R3 | taste receptor, type 1, member 3 | 1p36
| 3.591 |
| F10-AS1 | F10 antisense RNA 1 | 13q34
| 3.467 |
| RPS15 | ribosomal protein S15 | 19p13.3
| 3.445 |
| FAM120B | family with sequence similarity 120B | 6q27
| 3.433 |
| PCDHGA4 | protocadherin gamma subfamily A, 4 | 5q31
| 3.416 |
| NFIX | nuclear factor I/X (CCAAT-binding transcription factor) | 19p13.13
| 3.414 |
| CCDC166 | coiled-coil domain containing 166 | 8q24.3
| 3.395 |
| HSF4 | heat shock transcription factor 4 | 16q21
| 3.39 |
| MIR6808 | microRNA 6808 | 1
| 3.379 |
| LTK | leukocyte receptor tyrosine kinase | 15q15.1-q21.1
| 3.379 |
| ADPRHL1 | ADP-ribosylhydrolase like 1 | 13q34
| 3.378 |
| MMP23B | matrix metallopeptidase 23B | 1p36.3
| 3.359 |
| ANK1 | ankyrin 1, erythrocytic | 8p11.21
| 3.353 |
| MIR4664 | microRNA 4664 | 8
| 3.349 |
| CYP26A1 | cytochrome P450, family 26, subfamily A, polypeptide 1 | 10q23-q24
| 3.349 |
| ZNF865 | zinc finger protein 865 | 19q13.42
| 3.33 |
| PCSK4 | proprotein convertase subtilisin/kexin type 4 | 19p13.3
| 3.329 |
| FAM83H | family with sequence similarity 83, member H | 8q24.3
| 3.325 |
| PCDHA12 | protocadherin alpha 12 | 5q31
| 3.322 |
| CPTP | ceramide-1-phosphate transfer protein | 1p36.33
| 3.315 |
| CYP26C1 | cytochrome P450, family 26, subfamily C, polypeptide 1 | 10q23.33
| 3.313 |
| PCDHB19P | protocadherin beta 19 pseudogene | 5q31.3
| 3.312 |
| CPSF3L | cleavage and polyadenylation specific factor 3-like | 1p36.33
| 3.311 |
| MMP23A | matrix metallopeptidase 23A (pseudogene) | 1p36.3
| 3.311 |
| FAM83H-AS1 | FAM83H antisense RNA 1 (head to head) | 8q24.3
| 3.311 |
| FBXL8 | F-box and leucine-rich repeat protein 8 | 16q22.1-q22.3
| 3.303 |
| TRADD | TNFRSF1A-associated via death domain | 16q22
| 3.301 |
| ITPKA | inositol-trisphosphate 3-kinase A | 15q15.1
| 3.296 |
| MIR1909 | microRNA 1909 | 19p13.3
| 3.289 |
| MAPK15 | mitogen-activated protein kinase 15 | 8q24.3
| 3.288 |
| PCDHB18P | protocadherin beta 18 pseudogene | 5q31.3
| 3.278 |
| DLL1 | delta-like 1 (Drosophila) | 6q27
| 3.266 |
| REEP6 | receptor accessory protein 6 | 19p13.3
| 3.258 |
| ZNF784 | zinc finger protein 784 | 19q13.42
| 3.255 |
| C5orf66 | chromosome 5 open reading frame 66 | 5q31.1
| 3.237 |
| PITX1 | paired-like homeodomain 1 | 5q31.1
| 3.209 |
| SLC6A3 | solute carrier family 6 (neurotransmitter transporter), member 3 | 5p15.3
| 3.207 |
| POLR2E | polymerase (RNA) II (DNA directed) polypeptide E, 25kDa | 19p13.3
| 3.207 |
| ZNF764 | zinc finger protein 764 | 16p11.2
| 3.195 |
| PROZ | protein Z, vitamin K-dependent plasma glycoprotein | 13q34
| 3.195 |
| IRX2 | iroquois homeobox 2 | 5p15.33
| 3.182 |
| HOXC4 | homeobox C4 | 12q13.13
| 3.18 |
| TBX4 | T-box 4 | 17q21-q22
| 3.166 |
| PCDHB15 | protocadherin beta 15 | 5q31
| 3.153 |
| ATP8B3 | ATPase, aminophospholipid transporter, class I, type 8B, member 3 | 19p13.3
| 3.151 |
| SYNGR3 | synaptogyrin 3 | 16p13.3
| 3.148 |
| C5orf38 | chromosome 5 open reading frame 38 | 5p15.33
| 3.142 |
| B3GNT9 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 | 16q22.1
| 3.136 |
| F10 | coagulation factor X | 13q34
| 3.136 |
| SCARF2 | scavenger receptor class F, member 2 | 22q11.21
| 3.134 |
| CILP2 | cartilage intermediate layer protein 2 | 19p13.11
| 3.132 |
| PCDHA1 | protocadherin alpha 1 | 5q31
| 3.128 |
| FLJ32255 | NA | NA
| 3.11 |
| GPX4 | glutathione peroxidase 4 | 19p13.3
| 3.102 |
| C5orf66-AS1 | C5orf66 antisense RNA 1 | 5q31.1
| 3.096 |
| MIR6726 | microRNA 6726 | 1
| 3.09 |
| MIR6727 | microRNA 6727 | 1
| 3.083 |
| PCDHGB1 | protocadherin gamma subfamily B, 1 | 5q31
| 3.079 |
| LINC00685 | long intergenic non-protein coding RNA 685 | Xp22.33 and Yp11.32
| 3.058 |
| LOC100288123 | NA | NA
| 3.058 |
| MIR4745 | microRNA 4745 | 19
| 3.058 |
| DVL1 | dishevelled segment polarity protein 1 | 1p36
| 3.047 |
| GTPBP6 | GTP binding protein 6 (putative) | Xp22.33 and Yp11.32
| 3.047 |
| ZNF580 | zinc finger protein 580 | 19q13.42
| 3.037 |
| HOXA9 | homeobox A9 | 7p15.2
| 3.01 |
| ECEL1P2 | endothelin converting enzyme-like 1, pseudogene 2 | 2q37.1
| 3.01 |
| HOTTIP | HOXA distal transcript antisense RNA | 7p15.2
| 3.006 |
| HOXA13 | homeobox A13 | 7p15.2
| 3.005 |
| FLJ12825 | NA | NA
| 2.997 |
| MIR615 | microRNA 615 | 12q13.13
| 2.984 |
| KLF1 | Kruppel-like factor 1 (erythroid) | 19p13.2
| 2.984 |
| PUSL1 | pseudouridylate synthase-like 1 | 1p36.33
| 2.98 |
| JSRP1 | junctional sarcoplasmic reticulum protein 1 | 19p13.3
| 2.975 |
| ACAP3 | ArfGAP with coiled-coil, ankyrin repeat and PH domains 3 | 1p36
| 2.969 |
| ZNF524 | zinc finger protein 524 | 19q13.43
| 2.956 |
| TTC9B | tetratricopeptide repeat domain 9B | 19q13.2
| 2.952 |
| HOXC5 | homeobox C5 | 12q13.13
| 2.95 |
| DNASE2 | deoxyribonuclease II, lysosomal | 19p13.2
| 2.938 |
| ZNF581 | zinc finger protein 581 | 19q13.42
| 2.93 |
| FIZ1 | FLT3-interacting zinc finger 1 | 19q13.42
| 2.93 |
| C9orf172 | chromosome 9 open reading frame 172 | 9q34.3
| 2.93 |
| GFER | growth factor, augmenter of liver regeneration | 16p13.3-p13.12
| 2.929 |
| PCDHA13 | protocadherin alpha 13 | 5q31
| 2.923 |
| F7 | coagulation factor VII (serum prothrombin conversion accelerator) | 13q34
| 2.914 |
| FTCD | formimidoyltransferase cyclodeaminase | 21q22.3
| 2.905 |
| HIC1 | hypermethylated in cancer 1 | 17p13.3
| 2.904 |
| TRABD | TraB domain containing | 22q13.33
| 2.901 |
| NOL3 | nucleolar protein 3 (apoptosis repressor with CARD domain) | 16q22.1
| 2.899 |
| NOXO1 | NADPH oxidase organizer 1 | 16p13.3
| 2.882 |
| HOXA10-AS | HOXA10 antisense RNA | 7p15.2
| 2.881 |
| GSDMD | gasdermin D | 8q24.3
| 2.881 |
| OAZ1 | ornithine decarboxylase antizyme 1 | 19p13.3
| 2.878 |
| MIB2 | mindbomb E3 ubiquitin protein ligase 2 | 1p36.33
| 2.875 |
| HOXA7 | homeobox A7 | 7p15.2
| 2.869 |
| GRIN3B | glutamate receptor, ionotropic, N-methyl-D-aspartate 3B | 19p13.3
| 2.867 |
| MIR3187 | microRNA 3187 | 19
| 2.865 |
| MIR4321 | microRNA 4321 | 19
| 2.86 |
| MIR196B | microRNA 196b | 7p15.2
| 2.854 |
| CECR6 | cat eye syndrome chromosome region, candidate 6 | 22q11.2
| 2.85 |
| PRDM16 | PR domain containing 16 | 1p36.23-p33
| 2.841 |
| HELZ2 | helicase with zinc finger 2, transcriptional coactivator | 20q13.33
| 2.84 |
| C19orf35 | chromosome 19 open reading frame 35 | 19p13.3
| 2.837 |
| CEP72 | centrosomal protein 72kDa | 5p15.33
| 2.83 |
| LOC100996325 | NA | NA
| 2.83 |
| MXRA8 | matrix-remodelling associated 8 | 1p36.33
| 2.829 |
| CCDC106 | coiled-coil domain containing 106 | 19q13.42
| 2.828 |
| GJA3 | gap junction protein, alpha 3, 46kDa | 13q12.11
| 2.827 |
| GRTP1 | growth hormone regulated TBC protein 1 | 13q34
| 2.823 |
| PCDHB14 | protocadherin beta 14 | 5q31
| 2.822 |
| LOC100996342 | NA | NA
| 2.819 |
| EXOC3 | exocyst complex component 3 | 5p15.33
| 2.807 |
| EXOC3-AS1 | EXOC3 antisense RNA 1 | 5p15.33
| 2.807 |
| PRDM13 | PR domain containing 13 | 6q16.2
| 2.805 |
| MIR4635 | microRNA 4635 | 5
| 2.804 |
| SALL3 | spalt-like transcription factor 3 | 18q23
| 2.796 |
| PHPT1 | phosphohistidine phosphatase 1 | 9q34.3
| 2.784 |
| EPHX3 | epoxide hydrolase 3 | 19p13.13
| 2.779 |
| LINC00982 | long intergenic non-protein coding RNA 982 | 1p36.32
| 2.777 |
| HOXC6 | homeobox C6 | 12q13.13
| 2.774 |
| HOXA11-AS | HOXA11 antisense RNA | 7p15.2
| 2.771 |
| DEGS2 | delta(4)-desaturase, sphingolipid 2 | 14q32.2
| 2.766 |
| HOXA11 | homeobox A11 | 7p15.2
| 2.765 |
| PANX2 | pannexin 2 | 22q13.33
| 2.76 |
| AMH | anti-Mullerian hormone | 19p13.3
| 2.757 |
| RTN4RL1 | reticulon 4 receptor-like 1 | 17p13.3
| 2.757 |
| PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 19p13.11
| 2.748 |
| SOX1 | SRY (sex determining region Y)-box 1 | 13q34
| 2.746 |
| U2AF2 | U2 small nuclear RNA auxiliary factor 2 | 19q13.43
| 2.745 |
| ZNF688 | zinc finger protein 688 | 16p11.2
| 2.742 |
| MIR1237 | microRNA 1237 | 11
| 2.727 |
| ZIC2 | Zic family member 2 | 13q32
| 2.727 |
| GRIN2C | glutamate receptor, ionotropic, N-methyl D-aspartate 2C | 17q25.1
| 2.724 |
| HBQ1 | hemoglobin, theta 1 | 16p13.3
| 2.723 |
| LRRC24 | leucine rich repeat containing 24 | 8q24.3
| 2.721 |
| ABCA7 | ATP-binding cassette, sub-family A (ABC1), member 7 | 19p13.3
| 2.716 |
| HOXA10 | homeobox A10 | 7p15.2
| 2.714 |
| NPW | neuropeptide W | 16p13.3
| 2.71 |
| GCDH | glutaryl-CoA dehydrogenase | 19p13.2
| 2.704 |
| SIM1 | single-minded family bHLH transcription factor 1 | 6q16.3
| 2.7 |
| MIR6795 | microRNA 6795 | 19
| 2.696 |
| C8orf82 | chromosome 8 open reading frame 82 | 8q24
| 2.695 |
| NOTCH3 | notch 3 | 19p13.2-p13.1
| 2.687 |
| HOXA10-HOXA9 | NA | NA
| 2.679 |
| GRTP1-AS1 | GRTP1 antisense RNA 1 | 13q34
| 2.678 |
| WNT1 | wingless-type MMTV integration site family, member 1 | 12q13.12
| 2.676 |
| UNCX | UNC homeobox | 7p22.3
| 2.675 |
| ZIC5 | Zic family member 5 | 13q32.2
| 2.669 |
| PLEKHH3 | pleckstrin homology domain containing, family H (with MyTH4 domain) member 3 | 17q21.2
| 2.665 |
| MIR212 | microRNA 212 | 17p13.3
| 2.663 |
| TERT | telomerase reverse transcriptase | 5p15.33
| 2.654 |
| KEAP1 | kelch-like ECH-associated protein 1 | 19p13.2
| 2.653 |
| PDIA2 | protein disulfide isomerase family A, member 2 | 16p13.3
| 2.65 |
| MIR132 | microRNA 132 | 17p13.3
| 2.646 |
| GNAS | GNAS complex locus | 20q13.2-q13.3
| 2.632 |
| HBM | hemoglobin, mu | 16p13.3
| 2.632 |
| KIAA1875 | NA | NA
| 2.628 |
| TBL3 | transducin (beta)-like 3 | 16p13.3
| 2.627 |
| PCDHGA3 | protocadherin gamma subfamily A, 3 | 5q31
| 2.625 |
| CNTD2 | cyclin N-terminal domain containing 2 | 19q13.2
| 2.623 |
| TNFRSF6B | tumor necrosis factor receptor superfamily, member 6b, decoy | 20q13.33
| 2.623 |
| HBA1 | hemoglobin, alpha 1 | 16p13.3
| 2.622 |
| ARHGDIG | Rho GDP dissociation inhibitor (GDI) gamma | 16p13.3
| 2.618 |
| GBX1 | gastrulation brain homeobox 1 | 7q36.1
| 2.616 |
| C1QL4 | complement component 1, q subcomponent-like 4 | 12q13.12
| 2.614 |